Elevance Health earnings beat by $0.25, revenue topped estimates
Elevance Health earnings beat by $0.25, revenue topped estimates
ELV
+1.49%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
Investing.com – Elevance Health (NYSE: ELV) reported second quarter EPS of $9.04, $0.25 better than the analyst estimate of $8.79. Revenue for the quarter came in at $43.4B versus the consensus estimate of $41.64B.
Elevance Health’s stock price closed at $443.69. It is down -1.56% in the last 3 months and down -3.45% in the last 12 months.
Elevance Health saw 2 positive EPS revisions and 14 negative EPS revisions in the last 90 days. See Elevance Health’s stock price’s past reactions to earnings here.
According to InvestingPro, Elevance Health’s Financial Health score is “great performance”.
Check out Elevance Health’s recent earnings performance, and Elevance Health’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
